HomeLatestJapan approves 1st home COVID-19 variant vaccine

Japan approves 1st home COVID-19 variant vaccine

Japan on Tuesday introduced its first home COVID-19 vaccine in opposition to the Omicron XBB.1.5 coronavirus subvariant.

A Health Ministry panel mentioned that the vaccine developed by pharmaceutical agency Daiichi Sankyo is authorized for sensible use, Tokyo-based NHK news company reported.

Experts on the panel mentioned “they confirmed the vaccine’s effectiveness, and that they have no serious concerns over its safety.”

The vaccine can be distributed nationwide in December upon receiving ministry approval.

The ministry authorized Daiichi Sankyo’s plan to supply and promote 1.4 million doses of the XBB.1.5-adapted vaccine, resulting in the acquisition settlement.
…proceed studying

Dec 14 (ANNnewsCH) – 今月から国産の新型コロナのワクチン接種が初めて行われています。政府は140万回分を製薬会社から購入しています。  …proceed studying


Source

Latest